| Patent | Date |
|---|
Pharmaceutical Composition Which Can Be Used For Prevention And/or Treatment Of Acquired Hemophilia A, And Product Comprising Said Pharmaceutical Composition
App 20220305122 - Yoneyama; Koichiro ; et al. | 2022-09-29 |
Antibody Molecules
App 20220306755 - Igawa; Tomoyuki ; et al. | 2022-09-29 |
Tetracyclic Compound
App 20220306578 - KINOSHITA; Kazutomo ; et al. | 2022-09-29 |
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 11,454,633 - Ruike , et al. September 27, 2 | 2022-09-27 |
Subcutaneously Administered Anti-il-6 Receptor Antibody
App 20220280532 - Zhang; Xiaoping ; et al. | 2022-09-08 |
High Concentration Antibody-containing Liquid Formulation
App 20220281988 - MORICHIKA; Toshiyuki ; et al. | 2022-09-08 |
Method For The Production Of A Glycosylated Immunoglobulin
App 20220282298 - Franze; Reinhard ; et al. | 2022-09-08 |
Preparation containing tetracyclic compound at high dose
Grant 11,433,076 - Tomimatsu , et al. September 6, 2 | 2022-09-06 |
Anti-myostatin Antibodies And Methods Of Use
App 20220275076 - RUIKE; Yoshinao ; et al. | 2022-09-01 |
Anti-mutation Type Fgfr3 Antibody And Use Therefor
App 20220267452 - KAMIKAWAJI; Shogo ; et al. | 2022-08-25 |
Methods For Producing Polypeptides By Regulating Polypeptide Association
App 20220267822 - Igawa; Tomoyuki ; et al. | 2022-08-25 |
Multi-specific Antigen-binding Molecule Having Alternative Function To Function Of Blood Coagulation Factor Viii
App 20220267470 - Igawa; Tomoyuki ; et al. | 2022-08-25 |
Molecule Specifically Acting In A Tissue Where A Cell Death Is Being Observed
App 20220251166 - IGAWA; Tomoyuki ; et al. | 2022-08-11 |
Modified Antibody Constant Region
App 20220251225 - Igawa; Tomoyuki ; et al. | 2022-08-11 |
Information Processing System, Information Processing Method, Program, And Method For Producing Antigen-binding Molecule Or Protein
App 20220253669 - TERAMOTO; Reiji ; et al. | 2022-08-11 |
Dll3-targeting Multispecific Antigen-binding Molecules And Uses Thereof
App 20220251201 - Naoi; Sotaro ; et al. | 2022-08-11 |
Antigen-binding Molecule Containing Modified Fc Region
App 20220242934 - Igawa; Tomoyuki ; et al. | 2022-08-04 |
Antigen Binding Molecules That Bind Pdgf-b And Pdgf-d And Uses Thereof
App 20220242944 - KANAMORI; Masakazu ; et al. | 2022-08-04 |
Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion
Grant 11,400,157 - Igawa , et al. August 2, 2 | 2022-08-02 |
Hyaluronic acid derivatives into which cationic and hydrophobic groups are introduced
Grant 11,389,539 - Nakai , et al. July 19, 2 | 2022-07-19 |
Method For Diagnosing Endometriosis, Disease State Monitoring Method, And Kit
App 20220221472 - KOBAYASHI; Shinta ; et al. | 2022-07-14 |
Anti-il-6 Receptor Antibody-containing Inhibitor For Inhibiting Deterioration Of Bbb Function
App 20220220210 - Takeshita; Yukio ; et al. | 2022-07-14 |
Antibody Substituting For Function Of Blood Coagulation Factor Viii
App 20220213217 - Hattori; Kunihiro ; et al. | 2022-07-07 |
Method For Purifying Fc Region-modified Antibody
App 20220213140 - WAKABAYASHI; Tetsuya ; et al. | 2022-07-07 |
GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective
Grant 11,376,326 - Ohtomo , et al. July 5, 2 | 2022-07-05 |
Method for the production of a glycosylated immunoglobulin
Grant 11,377,678 - Franze , et al. July 5, 2 | 2022-07-05 |
MUTATED tRNA FOR CODON EXPANSION
App 20220205009 - SHINOHARA; Shojiro ; et al. | 2022-06-30 |
Therapeutic Agent For Urological Cancer Which Is Characterized By Being Administered With Il-6 Inhibitor And Ccr2 Inhibitor In Combination
App 20220204608 - Honda; Hiroaki ; et al. | 2022-06-30 |
Cross-species Anti-latent Tgf-beta 1 Antibodies And Methods Of Use
App 20220204605 - SHIMADA; Hideaki ; et al. | 2022-06-30 |
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
Grant 11,371,039 - Igawa , et al. June 28, 2 | 2022-06-28 |
Antibodies And Compositions For Use In Detecting Or Capturing A Polypeptide In A Sample, And Methods For Detecting Or Capturing A Polypeptide In A Sample
App 20220195070 - MATSUDA; Eriko ; et al. | 2022-06-23 |
Antigen-binding Molecule Containing Two Antigen-binding Domains That Are Linked To Each Other
App 20220195045 - SHIRAIWA; Hirotake ; et al. | 2022-06-23 |
Protein Purification Method
App 20220185843 - TAKEDA; Kozo ; et al. | 2022-06-16 |
Ion Concentration-dependent Binding Molecule Library
App 20220187308 - IGAWA; Tomoyuki ; et al. | 2022-06-16 |
Anti-il-31ra Antibody-containing Formulations
App 20220184210 - Kameoka; Daisuke ; et al. | 2022-06-16 |
Substrate, structure, structure-manufacturing method, cell-sorting method, cell-manufacturing method, and secretion-producing method
Grant 11,359,175 - Ohsaka , et al. June 14, 2 | 2022-06-14 |
High concentration antibody-containing liquid formulation
Grant 11,359,026 - Morichika , et al. June 14, 2 | 2022-06-14 |
Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
Grant 11,359,194 - Igawa , et al. June 14, 2 | 2022-06-14 |
Anti-myostatin antibodies and methods of use
Grant 11,359,009 - Ruike , et al. June 14, 2 | 2022-06-14 |
Treatment Of Skin Lesions And Pruritus In Prurigo Nodularis Patients
App 20220177568 - PIKETTY; Christophe | 2022-06-09 |
Therapeutic Agents For Pancreatic Cancer
App 20220175919 - MITSUNAGA; Shuichi ; et al. | 2022-06-09 |
Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor X
Grant 11,352,438 - Yoneyama , et al. June 7, 2 | 2022-06-07 |
Method Of Introducing Target-specific Foreign Gene
App 20220170047 - KOMATSU; Shodai ; et al. | 2022-06-02 |
Hydantoin Derivative
App 20220162208 - NISHIMURA; Yoshikazu ; et al. | 2022-05-26 |
Cancer Vaccine Formulation
App 20220160849 - SHIKU; Hiroshi ; et al. | 2022-05-26 |
Antigen-binding Molecule Containing Antigen-binding Domain Of Which Binding Activity To Antigen Is Changed Depending On Mta, And Library For Obtaining Said Antigen-binding Domain
App 20220153875 - Mizuno; Hideaki ; et al. | 2022-05-19 |
Anti-hla-dq2.5 Antibody
App 20220153847 - Okura; Yuu ; et al. | 2022-05-19 |
Modified antibody constant region
Grant 11,332,533 - Igawa , et al. May 17, 2 | 2022-05-17 |
Method For Preparing Aromatic Amino Acid Derivative
App 20220144762 - WADAMOTO; Manabu | 2022-05-12 |
Chimeric Receptor That Recognizes Engineered Site In Antibody
App 20220143094 - Sakurai; Mika ; et al. | 2022-05-12 |
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20220135618 - Igawa; Tomoyuki ; et al. | 2022-05-05 |
Antibody-containing Formulations
App 20220125921 - Kameoka; Daisuke ; et al. | 2022-04-28 |
Method For Treating And/or Preventing Regnase-1-related Disease
App 20220125891 - AKIRA; Shizuo ; et al. | 2022-04-28 |
Cross-species anti-latent TGF-beta 1 antibodies
Grant 11,312,767 - Shimada , et al. April 26, 2 | 2022-04-26 |
Antibody Having Enhanced Activity, And Method For Modifying Same
App 20220119551 - Igawa; Tomoyuki ; et al. | 2022-04-21 |
Antigen-binding Molecule Comprising Altered Antibody Variable Region
App 20220112296 - Igawa; Tomoyuki ; et al. | 2022-04-14 |
Self-emulsifying Drug Formulation For Improving Membrane Permeability Of Compound
App 20220096379 - TAMPO; Yoshihiro ; et al. | 2022-03-31 |
Therapeutic agents for pancreatic cancer
Grant 11,285,208 - Mitsunaga , et al. March 29, 2 | 2022-03-29 |
Novel Cancer Antigens And Antibodies Of Said Antigens
App 20220089770 - NEZU; Junichi ; et al. | 2022-03-24 |
Anti-hla-dq2.5 Antibody And Its Use For The Treatment Of Celiac Disease
App 20220089743 - Ikawa; Yuri ; et al. | 2022-03-24 |
Methods Of Neutralizing Il-8 Biological Activity
App 20220089715 - IGAWA; Tomoyuki ; et al. | 2022-03-24 |
Therapeutic agent for a lung disease and/or method for screening for the same
Grant 11,279,931 - Kishimoto , et al. March 22, 2 | 2022-03-22 |
CD3-targeting and DLL3-targeting multispecific antigen-binding molecules and uses thereof
Grant 11,274,151 - Naoi , et al. March 15, 2 | 2022-03-15 |
Antigen-binding Domain, And Polypeptide Including Conveying Section
App 20220073632 - IGAWA; Tomoyuki ; et al. | 2022-03-10 |
Pharmaceutical Composition For Use In Prevention And/or Treatment Of Disease That Develops Or Progresses As A Result Of Decrease Or Loss Of Activity Of Blood Coagulation Factor Viii And/or Activated Blood Coagulation Factor Viii
App 20220073645 - Yoneyama; Koichiro | 2022-03-10 |
Bispecific Antibody Exhibiting Increased Alternative Fviii-cofactor-function Activity
App 20220073644 - Igawa; Tomoyuki ; et al. | 2022-03-10 |
Fc region variant
Grant 11,267,868 - Mimoto , et al. March 8, 2 | 2022-03-08 |
Antibody Constant Region Variant
App 20220064264 - Igawa; Tomoyuki ; et al. | 2022-03-03 |
Anti-IL31RA antibody-containing formulations
Grant 11,260,125 - Kameoka , et al. March 1, 2 | 2022-03-01 |
Method of modifying isoelectric point of antibody via amino acid substitution in CDR
Grant 11,248,053 - Igawa , et al. February 15, 2 | 2022-02-15 |
Library Of Antigen-binding Molecules Including Modified Antibody Variable Region
App 20220040297 - Igawa; Tomoyuki ; et al. | 2022-02-10 |
Antibody Molecules
App 20220041741 - Igawa; Tomoyuki ; et al. | 2022-02-10 |
Cytotoxicity-inducing Therapeutic Agent
App 20220041756 - Nezu; Junichi ; et al. | 2022-02-10 |
Ion concentration-dependent binding molecule library
Grant 11,243,210 - Igawa , et al. February 8, 2 | 2022-02-08 |
Her2 S310f Specific Antigen-binding Molecules
App 20220033516 - KODAMA; Tatsushi ; et al. | 2022-02-03 |
Mouse Fc.gamma.ammaRII-specific Fc antibody
Grant 11,236,168 - Igawa , et al. February 1, 2 | 2022-02-01 |
Treatment of skin lesions and pruritus in prurigo nodularis patients
Grant 11,236,157 - Piketty February 1, 2 | 2022-02-01 |
Deprotection Method And Resin Removal Method In Solid-phase Reaction For Peptide Compound Or Amide Compound, And Method For Producing Peptide Compound
App 20220024972 - IWASAKI; Kotaro ; et al. | 2022-01-27 |
O-substituted Serine Derivative Production Method
App 20220017456 - ISHIZAWA; Takenori | 2022-01-20 |
Cxcr3 Ligand
App 20220017585 - YAMAMOTO; Yohei ; et al. | 2022-01-20 |
Method For Producing Polypeptide Hetero-oligomer
App 20220010030 - Igawa; Tomoyuki ; et al. | 2022-01-13 |
Antibody capable of neutralizing substance having activity alternative to function of coagulation factor VIII (FVIII)
Grant 11,214,623 - Igawa , et al. January 4, 2 | 2022-01-04 |
Cross-species Anti-latent Tgf-beta 1 Antibodies And Methods Of Use
App 20210395356 - SHIMADA; Hideaki ; et al. | 2021-12-23 |
Antigen-binding Molecules Capable Of Binding Cd3 And Cd137 But Not Simultaneously
App 20210388087 - Ho; Shu Wen Samantha ; et al. | 2021-12-16 |
Cell Injury Inducing Therapeutic Drug For Use In Cancer Therapy
App 20210388110 - KINOSHITA; Yasuko ; et al. | 2021-12-16 |
Method For The Production Of A Glycosylated Immunoglobulin
App 20210381020 - Franze; Reinhard ; et al. | 2021-12-09 |
Antibody Substituting For Function Of Blood Coagulation Factor Viii
App 20210380717 - Hattori; Kunihiro ; et al. | 2021-12-09 |
Anti-dll3 Antibody
App 20210380715 - YOSHIDA; Kenji ; et al. | 2021-12-09 |
Hyaluronic Acid Derivative Modified With Polyethylene Glycol
App 20210371548 - HATTORI; Kazuo ; et al. | 2021-12-02 |
Cytotoxicity-inducing Therapeutic Agent
App 20210363250 - KAMIKAWAJI; Shogo ; et al. | 2021-11-25 |
Methods of neutralizing IL-8 biological activity
Grant 11,180,548 - Igawa , et al. November 23, 2 | 2021-11-23 |
Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient
Grant 11,174,317 - Kunugi , et al. November 16, 2 | 2021-11-16 |
Antigen-binding domain, and polypeptide including conveying section
Grant 11,168,139 - Igawa , et al. November 9, 2 | 2021-11-09 |
Methods for producing polypeptides by regulating polypeptide association
Grant 11,168,344 - Igawa , et al. November 9, 2 | 2021-11-09 |
Library of antigen-binding molecules including modified antibody variable region
Grant 11,154,615 - Igawa , et al. October 26, 2 | 2021-10-26 |
Methods For Controlling Blood Pharmacokinetics Of Antibodies
App 20210324109 - Igawa; Tomoyuki ; et al. | 2021-10-21 |
Combination Drug
App 20210322380 - SAKAMOTO; Hiroshi ; et al. | 2021-10-21 |
Anti-cd137 Antigen-binding Molecule And Utilization Thereof
App 20210324099 - IGAWA; Tomoyuki ; et al. | 2021-10-21 |
Antibody-containing Formulations
App 20210322550 - Kameoka; Daisuke ; et al. | 2021-10-21 |
Method for measuring reactivity of FVIII
Grant 11,150,254 - Nogami , et al. October 19, 2 | 2021-10-19 |
Method for producing polypeptide hetero-oligomer
Grant 11,142,587 - Igawa , et al. October 12, 2 | 2021-10-12 |
Antigen-binding molecule containing modified Fc region
Grant 11,142,563 - Igawa , et al. October 12, 2 | 2021-10-12 |
Method for the production of a glycosylated immunoglobulin
Grant 11,136,610 - Franze , et al. October 5, 2 | 2021-10-05 |
Method for production of antibody
Grant 11,136,375 - Yamada , et al. October 5, 2 | 2021-10-05 |
Method For Production Of Antibody
App 20210300996 - YAMADA; Yoshiki ; et al. | 2021-09-30 |
A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventing A C5-related Disease
App 20210301004 - SHINOMIYA; Kenji ; et al. | 2021-09-30 |
Composition For Prophylaxis Or Treatment Of Il-8 Related Diseases
App 20210301011 - KAKIUCHI; Ayako ; et al. | 2021-09-30 |
Dll3-targeting Multispecific Antigen-binding Molecules And Uses Thereof
App 20210301016 - Naoi; Sotaro ; et al. | 2021-09-30 |
Solid Dispersion Of Hydantoin Derivative
App 20210290541 - KINOSHITA; Ryo ; et al. | 2021-09-23 |
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20210292360 - Igawa; Tomoyuki ; et al. | 2021-09-23 |
Method For Culturing Cancer Tissue Or Tissue Analogous To Cancer Tissue
App 20210293769 - KAWAI; Shigeto ; et al. | 2021-09-23 |
Target Cell Specific Cytosol-penetrating Antigen-binding Molecules
App 20210292409 - IKAWA; Yuri ; et al. | 2021-09-23 |
Pharmaceutical Composition Containing Poorly-soluble Basic Medicine
App 20210290630 - KITAYAMA; Akira ; et al. | 2021-09-23 |
Method for producing polypeptide heteromultimer
Grant 11,124,576 - Igawa , et al. September 21, 2 | 2021-09-21 |
Cancer stem cell population and method for production thereof
Grant 11,124,773 - Yamazaki , et al. September 21, 2 | 2021-09-21 |
Method For Treating Rheumatoid Arthritis With A Human Il-6 Receptor Antibody And Methotrexate
App 20210283250 - OKUDA; Osamu ; et al. | 2021-09-16 |
Anti-DLL3 antibody
Grant 11,111,311 - Yoshida , et al. September 7, 2 | 2021-09-07 |
Process Of Production With Controlled Copper Ions
App 20210269536 - YAMAMOTO; Seiko ; et al. | 2021-09-02 |
FCgammaRIIB-SPECIFIC FC REGION VARIANT
App 20210261648 - Katada; Hitoshi ; et al. | 2021-08-26 |
Method For Activating Immune Response Of Target Cell And Composition Therefor
App 20210261669 - SAKASHITA; Takuya ; et al. | 2021-08-26 |
Ligand-binding Molecule Containing Single Domain Antibody
App 20210253672 - ISHIKAWA; Hiroyuki ; et al. | 2021-08-19 |
Method For The Production Of A Glycosylated Immunoglobulin
App 20210246478 - Franze; Reinhard ; et al. | 2021-08-12 |
High Concentration Antibody-containing Liquid Formulation
App 20210246216 - MORICHIKA; Toshiyuki ; et al. | 2021-08-12 |
Recombinant Polypeptide Production Method
App 20210246193 - TABUCHI; Hisahiro ; et al. | 2021-08-12 |
Amorphous Form Of Tetracyclic Compound
App 20210238160 - Shiraki; Koji ; et al. | 2021-08-05 |
Antigen-binding Molecule Showing Changed Half-life In Cytoplasm
App 20210238308 - IKAWA; Yuri ; et al. | 2021-08-05 |
Pharmaceutical Composition For Use In Prevention And/or Treatment Of Disease That Develops Or Progresses As A Result Of Decrease Or Loss Of Activity Of Blood Coagulation Factor Viii And/or Activated Blood Coagulation Factor Viii
App 20210238307 - Yoneyama; Koichiro | 2021-08-05 |
Combination drug
Grant 11,077,093 - Sakamoto , et al. August 3, 2 | 2021-08-03 |
Method for evaluating blood coagulation reaction
Grant 11,078,518 - Soeda , et al. August 3, 2 | 2021-08-03 |
Subcutaneously Administered Anti-il-6 Receptor Antibody
App 20210228597 - ZHANG; XIAOPING ; et al. | 2021-07-29 |
Filling Nozzle
App 20210229848 - NISHIZAWA; Shaw | 2021-07-29 |
Method For Detecting Complex
App 20210231654 - NAOI; Sotaro ; et al. | 2021-07-29 |
Cytotoxicity-inducing Therapeutic Agent
App 20210230311 - NEZU; Junichi ; et al. | 2021-07-29 |
Cell injury inducing therapeutic drug for use in cancer therapy
Grant 11,072,666 - Kinoshita , et al. July 27, 2 | 2021-07-27 |
Polypeptide Comprising Aggrecan Binding Domain And Carrying Moiety
App 20210221875 - KITAMURA; Hidetomo ; et al. | 2021-07-22 |
Cytotoxicity-inducing therapeutic agent
Grant 11,066,483 - Nezu , et al. July 20, 2 | 2021-07-20 |
Method for measuring viscosity of protein solution
Grant 11,059,881 - Fukuda , et al. July 13, 2 | 2021-07-13 |
Method For Inducing Differentiation Of Pluripotent Stem Cells Into Hepatocytes
App 20210207085 - KUME; Shoen ; et al. | 2021-07-08 |
Ligand-binding Molecule Having Adjustable Ligand-binding Activity
App 20210206845 - IGAWA; Tomoyuki ; et al. | 2021-07-08 |
Anti-il-6 Receptor Antibody
App 20210206862 - Igawa; Tomoyuki ; et al. | 2021-07-08 |
Method for treating IL-8-related diseases
Grant 11,053,308 - Kakiuchi , et al. July 6, 2 | 2021-07-06 |
Urokinase-type plasminogen activator transgenic mouse
Grant 11,051,496 - Kohara , et al. July 6, 2 | 2021-07-06 |
Anti-complement Component Antibodies And Methods Of Use
App 20210198347 - FUKUZAWA; Taku ; et al. | 2021-07-01 |
Pharmaceutical Composition
App 20210198364 - Iwai; Toshiki ; et al. | 2021-07-01 |
Lyophilized Formulation Sealed In Glass Container
App 20210196568 - YAMASHITA; Shogo ; et al. | 2021-07-01 |
Methods for controlling blood pharmacokinetics of antibodies
Grant 11,046,784 - Igawa , et al. June 29, 2 | 2021-06-29 |
Process of production with controlled copper ions
Grant 11,046,772 - Yamamoto , et al. June 29, 2 | 2021-06-29 |
Antibody-containing Preparation
App 20210189006 - SAEKI; Atsushi ; et al. | 2021-06-24 |
Antibody Half-molecule, And Method For Inhibiting Homodimer Formation Of Antibody Half-molecule
App 20210188957 - KAWA; Tatsuya | 2021-06-24 |
Method For Measuring Cellular Uptake Of Molecules
App 20210190764 - NOGUCHI; Yuki ; et al. | 2021-06-24 |
Antigen-binding Molecules, The Antigen-binding Activity Of Which Varies According To The Concentration Of Compounds, And Libraries Of Said Molecules
App 20210180049 - Igawa; Tomoyuki ; et al. | 2021-06-17 |
Method For Treating Rheumatoid Arthritis With A Human Il-6 Receptor Antibody And Methotrexate
App 20210170024 - OKUDA; Osamu ; et al. | 2021-06-10 |
Recombinant polypeptide production method
Grant 11,028,149 - Tabuchi , et al. June 8, 2 | 2021-06-08 |
Therapeutic Agents For Ocular Inflammatory Disease Comprising Interleukin 6 Receptor Inhibitor As Active Ingredient
App 20210163608 - OHGURO; Nobuyuki ; et al. | 2021-06-03 |
Method for the production of a glycosylated immunoglobulin
Grant 11,021,728 - Franze , et al. June 1, 2 | 2021-06-01 |
Polypeptide Comprising Il-1r1 Binding Domain And Carrying Moiety
App 20210155701 - HOSHINO; Maiko ; et al. | 2021-05-27 |
Method For Producing Cyclic Organic Compound
App 20210147475 - HOMMA; Akie ; et al. | 2021-05-20 |
High concentration antibody-containing liquid formulation
Grant 11,008,394 - Morichika , et al. May 18, 2 | 2021-05-18 |
Cytotoxicity-inducing therapeutic agent
Grant 11,001,643 - Nezu , et al. May 11, 2 | 2021-05-11 |
Antigen-binding Molecule For Eliminating Aggregated Antigens
App 20210122812 - Igawa; Tomoyuki ; et al. | 2021-04-29 |
Anti-masp-1 Antibodies And Methods Of Use
App 20210115154 - RUIKE; Yoshinao ; et al. | 2021-04-22 |
Cross-species Anti-latent Tgf-beta 1 Antibodies And Methods Of Use
App 20210115122 - KANAMORI; Masakazu | 2021-04-22 |
Medicinal Composition Usable For Preventing And/or Treating Blood Coagulation Factor Ix Abnormality, Comprising Multispecific Antigen Binding Molecule Replacing Function Of Blood Coagulation Factor Viii
App 20210107994 - Shima; Midori ; et al. | 2021-04-15 |
Antibody Substituting For Function Of Blood Coagulation Factor Viii
App 20210107995 - Hattori; Kunihiro ; et al. | 2021-04-15 |
Anti-dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20210095008 - SAMPEI; Zenjiro ; et al. | 2021-04-01 |
Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
Grant 10,961,530 - Igawa , et al. March 30, 2 | 2021-03-30 |
MODIFIED AMINOACYL-tRNA SYNTHETASE AND USE THEREOF
App 20210087572 - OHTA; Atsushi ; et al. | 2021-03-25 |
Antigen-binding Molecule Capable Of Binding Two Or More Antigen Molecules Repeatedly
App 20210079378 - IGAWA; Tomoyuki ; et al. | 2021-03-18 |
Antigen-binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
App 20210079379 - IGAWA; Tomoyuki ; et al. | 2021-03-18 |
Peptide-compound Cyclization Method
App 20210061860 - KARIYUKI; Shiori ; et al. | 2021-03-04 |
Methods of modifying antibodies for purification of bispecific antibodies
Grant 10,934,344 - Igawa , et al. March 2, 2 | 2021-03-02 |
Cancer stem cell-specific molecule
Grant 10,934,351 - Yamazaki , et al. March 2, 2 | 2021-03-02 |
Composition Comprising Tetracyclic Compound
App 20210052550 - FURUMOTO; Kentaro ; et al. | 2021-02-25 |
Cytotoxicity-inducing Therapeutic Agent
App 20210054076 - KIMURA; Naoki | 2021-02-25 |
FcgammaRIIB-specific Fc region variant
Grant 10,919,953 - Katada , et al. February 16, 2 | 2021-02-16 |
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20210040147 - Igawa; Tomoyuki ; et al. | 2021-02-11 |
Anti-c1s Antibodies And Methods Of Use
App 20210032365 - FENG; Shu ; et al. | 2021-02-04 |
Hydantoin Derivative
App 20210024524 - Nishimura; Yoshikazu ; et al. | 2021-01-28 |
Stable protein-containing preparation containing argininamide or analogous compound thereof
Grant 10,898,572 - Kameoka , et al. January 26, 2 | 2021-01-26 |
Composition For Treating Il-6-related Diseases
App 20210017286 - Kakehi; Takahiro ; et al. | 2021-01-21 |
Anti-dengue Virus Antibodies Having Cross-reactivity To Zika Virus And Methods Of Use
App 20210017256 - FINK; Katja ; et al. | 2021-01-21 |
Pyrazolopyridine Derivative Having Glp-1 Receptor Agonist Effect
App 20210017176 - YOSHINO; Hitoshi ; et al. | 2021-01-21 |
Pharmaceutical Composition For Use In Prevention And/or Treatment Of Disease That Develops Or Progresses As A Result Of Decrease Or Loss Of Activity Of Blood Coagulation Factor Viii And/or Activated Blood Coagulation Factor Viii
App 20200407463 - Yoneyama; Koichiro | 2020-12-31 |
Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventing A C5-related Disease
App 20200407432 - SHINOMIYA; Kenji ; et al. | 2020-12-31 |
Subcutaneously administered anti-IL-6 receptor antibody
Grant 10,874,677 - Zhang , et al. December 29, 2 | 2020-12-29 |
Pharmaceutical Composition Comprising Non-ionic Surfactants
App 20200397794 - Meier; Susanne ; et al. | 2020-12-24 |
Antigen-binding Molecule And Combination
App 20200399373 - IGAWA; Tomoyuki ; et al. | 2020-12-24 |
Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe Excoriation
App 20200385476 - KERROUCHE; Nabil ; et al. | 2020-12-10 |
Cancer Stem Cell Population And Method For Production Thereof
App 20200385686 - Yamazaki; Tatsumi ; et al. | 2020-12-10 |
Fgfr3 Fusion Gene And Pharmaceutical Drug Targeting Same
App 20200385812 - Nakanishi; Yoshito ; et al. | 2020-12-10 |
Method for purifying composition comprising antibodies with anionic polymer
Grant 10,858,391 - Ito , et al. December 8, 2 | 2020-12-08 |
Pyrazolopyridine derivative having GLP-1 receptor agonist effect
Grant 10,858,356 - Yoshino , et al. December 8, 2 | 2020-12-08 |
Antigen-binding Molecule Comprising Altered Antibody Variable Region Binding Cd3 And Cd137
App 20200377595 - Shimizu; Shun ; et al. | 2020-12-03 |
Antibodies, Compositions For Use In Detecting Or Capturing A Polypeptide In A Sample, And Methods For Detecting Or Capturing A Polypeptide In A Sample
App 20200369784A1 - | 2020-11-26 |
Polypeptide Including Antigen-binding Domain And Carrying Section
App 20200369781A1 - | 2020-11-26 |
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,844,113 - Sampei , et al. November 24, 2 | 2020-11-24 |
Multispecific Antigen-binding Molecules Having Blood Coagulation Factor Viii (fviii) Cofactor Function-substituting Activity And Pharmaceutical Formulations Containing Such A Molecule As An Active Ingredient
App 20200354473A1 - | 2020-11-12 |
Gene knock-in non-human animal
Grant 10,822,420 - Jishage , et al. November 3, 2 | 2020-11-03 |
Method For Producing Peptide, And Method For Processing Bases
App 20200339623A1 - | 2020-10-29 |
Modified aminoacyl-tRNA synthetase and use thereof
Grant 10,815,489 - Ohta , et al. October 27, 2 | 2020-10-27 |
Antigen-binding Molecule Containing Modified Antibody Variable Region
App 20200332001A1 - | 2020-10-22 |
Cancer Stem Cell-specific Molecule
App 20200325222A1 - | 2020-10-15 |
Anti-myostatin Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
App 20200317768A1 - | 2020-10-08 |
Anti-hla-dq2.5 Antibody
App 20200317790A1 - | 2020-10-08 |
Anti-il-6 Receptor Antibody-containing Medicinal Composition For Preventing Post-surgical Adhesion
App 20200299391A1 - | 2020-09-24 |
Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
Grant 10,782,290 - Yamamura , et al. Sept | 2020-09-22 |
GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy
Grant 10,782,300 - Ohtomo , et al. Sept | 2020-09-22 |
Composition for treating IL-6-related diseases
Grant 10,774,148 - Kakehi , et al. Sept | 2020-09-15 |
Amorphous form of tetracyclic compound
Grant 10,774,067 - Shiraki , et al. Sept | 2020-09-15 |
Antibody Variant And Isoform With Lowered Biological Activity
App 20200283544A1 - | 2020-09-10 |
Heterodimerized polypeptide
Grant 10,766,960 - Igawa , et al. Sep | 2020-09-08 |
Antiplexin A1 Agonist Antibody
App 20200276302A1 - | 2020-09-03 |
Antibody Substituting For Function Of Blood Coagulation Factor Viii
App 20200277402A1 - | 2020-09-03 |
Method For Synthesizing Peptide Containing N-substituted Amino Acid
App 20200277327A1 - | 2020-09-03 |
Multispecific antigen-binding molecules having blood coagulation factor VIII (FVIII) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ingredient
Grant 10,759,870 - Teranishi , et al. Sep | 2020-09-01 |
Antibody Having Enhanced Activity, And Method For Modifying Same
App 20200270363A1 - | 2020-08-27 |
Method for treating rheumatoid arthritis with a human IL-6 receptor antibody and methotrexate
Grant 10,744,201 - Okuda , et al. A | 2020-08-18 |
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,738,111 - Ruike , et al. A | 2020-08-11 |
Ret Inhibitor
App 20200246349A1 - | 2020-08-06 |
Treatment Of Skin Lesions And Pruritus In Prurigo Nodularis Patients
App 20200239563A1 - | 2020-07-30 |
Protein Purification Method
App 20200231624A1 - | 2020-07-23 |
Antibody Molecules
App 20200231688A1 - | 2020-07-23 |
Gene-modified Non-human Animal Expressing Human Gpc3 Polypeptide
App 20200229408A9 - | 2020-07-23 |
Method for identifying epitope on protein
Grant 10,718,781 - Inoue , et al. | 2020-07-21 |
Multispecific Antigen-binding Molecules Having Blood Coagulation Factor Viii (fviii) Cofactor Function-substituting Activity And Pharmaceutical Formulations Containing Such A Molecule As An Active Ingredient
App 20200223940A1 - | 2020-07-16 |
Dosage Regimen For Combination Therapy Using Pd-1 Axis Binding Antagonists And Gpc3 Targeting Agent
App 20200216542A1 - | 2020-07-09 |
Polypeptide Modification Method For Purifying Polypeptide Multimers
App 20200207805A1 - | 2020-07-02 |
Ligand-binding Molecule Having Adjustable Ligand Binding Activity
App 20200207846A1 - | 2020-07-02 |
Method for determining application of therapy to multiple sclerosis (MS) patient
Grant 10,697,883 - Yamamura , et al. | 2020-06-30 |
Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies
Grant 10,696,743 - Aburatani , et al. June 30, 2 | 2020-06-30 |
Method For Altering Plasma Retention And Immunogenicity Of Antigen-binding Molecule
App 20200199241A1 - | 2020-06-25 |
AntiPlexin A1 agonist antibody
Grant 10,688,178 - Kumanogoh , et al. | 2020-06-23 |
FGFR3 fusion gene and pharmaceutical drug targeting same
Grant 10,689,705 - Nakanishi , et al. | 2020-06-23 |
Protein Purification With Protein L
App 20200190138A1 - | 2020-06-18 |
Method For Evaluating Immunogenicity Of Test Substance
App 20200191770A1 - | 2020-06-18 |
Method For The Production Of A Glycosylated Immunoglobulin
App 20200181669A1 - | 2020-06-11 |
MODIFIED Fc REGION OF ANTIBODY
App 20200181257A1 - | 2020-06-11 |
Antibody Against Secreted N-terminal Peptide Of Gpc3 Present In Blood Or C-terminal Peptide Of Gpc3
App 20200181248A1 - | 2020-06-11 |
ANTIBODIES COMPRISING AN ANTIGEN-BINDING DOMAIN WHOSE ANTIGEN-BINDING ACTIVITY CHANGES ACCORDING TO THE ION CONCENTRATION CONDITION, Fc REGION VARIANTS, OR IL-8-BINDING ANTIBODIES
App 20200172610A1 - | 2020-06-04 |
Method For Preparing A Composition Comprising Highly Concentrated Antibodies By Ultrafiltration
App 20200172569A1 - | 2020-06-04 |
RET inhibitor
Grant 10,668,075 - Kodama , et al. | 2020-06-02 |
Methods of reducing IL-6 activity for disease treatment
Grant 10,662,245 - Igawa , et al. | 2020-05-26 |
Diagnosis And Treatment Of Cancer Using Anti-lgr7 Antibody
App 20200157231A1 - | 2020-05-21 |
Pharmaceutical Composition For Use In Prevention And/or Treatment Of Disease That Develops Or Progresses As A Result Of Decrease Or Loss Of Activity Of Blood Coagulation Factor Viii And/or Activated Blood Coagulation Factor Viii
App 20200157243A1 - | 2020-05-21 |
Method for removing viruses in a physiologically-active protein-containing sample
Grant 10,654,888 - Takeda , et al. | 2020-05-19 |
Method for purifying antibody having low isoelectric point
Grant 10,654,933 - Ueda , et al. | 2020-05-19 |
Subtypes Of Humanized Antibody Against Interleukin-6 Receptor
App 20200148775A1 - | 2020-05-14 |
Method For Predicting And Evaluating Therapeutic Effect In Diseases Related To Il-6 And Neutrophils
App 20200148760A1 - | 2020-05-14 |
Composition comprising tetracyclic compound
Grant 10,646,468 - Furumoto , et al. | 2020-05-12 |
Novel Therapeutic Agent For A Lung Disease And/or Method For Screening For The Same
App 20200140862A1 - | 2020-05-07 |
Cyclic Peptide Compound Having High Membrane Permeability, And Library Containing Same
App 20200131669A1 - | 2020-04-30 |
Method For Measuring Viscosity Of Protein Solution
App 20200131250A1 - | 2020-04-30 |
Cytotoxicity-inducing Therapeutic Agent
App 20200123256A1 - | 2020-04-23 |
Antigen-binding Molecule Inducing Immune Response To Target Antigen
App 20200115447A1 - | 2020-04-16 |
Method for altering plasma retention and immunogenicity of antigen-binding molecule
Grant 10,618,965 - Igawa , et al. | 2020-04-14 |
Coagulation Factor Ix With Improved Pharmacokinetics
App 20200109390A1 - | 2020-04-09 |
Pharmaceutical Composition For Prevention And/or Treatment Of Atopic Dermatitis Comprising Il-31 Antagonist As Active Ingredient
App 20200102396A1 - | 2020-04-02 |
Anti-dengue virus antibodies, polypeptides containing variant Fc regions, and methods of use
Grant 10,604,561 - Sampei , et al. | 2020-03-31 |
Antigen-binding Molecule Having Regulated Conjugation Between Heavy-chain And Light-chain
App 20200087380A1 - | 2020-03-19 |
Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
Grant 10,590,164 - Lau , et al. | 2020-03-17 |
High Concentration Antibody-containing Liquid Formulation
App 20200079857A1 - | 2020-03-12 |
Method For The Production Of A Glycosylated Immunoglobulin
App 20200080125A1 - | 2020-03-12 |
Use of RHOA in cancer diagnosis and inhibitor screening
Grant 10,563,265 - Aburatani , et al. Feb | 2020-02-18 |
Antigen-binding Molecule Capable Of Binding To Two Or More Antigen Molecules Repeatedly
App 20200048627A1 - | 2020-02-13 |
Cell Injury Inducing Therapeutic Drug For Use In Cancer Therapy
App 20200048361A1 - | 2020-02-13 |
Antigen-binding molecule inducing immune response to target antigen
Grant 10,556,949 - Igawa , et al. Feb | 2020-02-11 |
Anti-hla-dq2.5/8 Antibody And Its Use For The Treatment Of Celiac Disease
App 20200040085A1 - | 2020-02-06 |
Method For Synthesizing Peptides In Cell-free Translation System
App 20200040372A1 - | 2020-02-06 |
Preparation Containing Tetracyclic Compound At High Dose
App 20200038407A1 - | 2020-02-06 |
Therapeutic agent for a lung disease and/or method for screening for the same
Grant 10,550,387 - Kishimoto , et al. Fe | 2020-02-04 |
Anti-c5 Antibodies And Methods Of Use
App 20200031913A1 - | 2020-01-30 |
Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient
Grant 10,544,227 - Kaneko , et al. Ja | 2020-01-28 |
Tetracyclic Compound
App 20200017442A1 - | 2020-01-16 |
Anti-nr10 Antibody And Use Thereof
App 20200002429A1 - | 2020-01-02 |
Nucleic acids encoding IL-8 antibodies
Grant 10,519,229 - Igawa , et al. Dec | 2019-12-31 |
Self-emulsifying Drug Formulation For Improving Membrane Permeability Of Compound
App 20190380958A1 - | 2019-12-19 |
Pharmaceutical Composition, Antigen-binding Molecules, Treatment Method, And Screening Method
App 20190382484A1 - | 2019-12-19 |
Method for producing antigen-binding molecule using modified helper phage
Grant 10,501,737 - Ishii Dec | 2019-12-10 |
Method for the production of a glycosylated immunoglobulin
Grant 10,501,769 - Franze , et al. Dec | 2019-12-10 |
Method for detecting lung squamous cell carcinoma
Grant 10,502,743 - Isoda , et al. Dec | 2019-12-10 |
Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-related Disease And A Method For Treating Or Preventing A C5-related Disease
App 20190367599A1 - | 2019-12-05 |
Fgfr Gatekeeper Mutant Gene And Drug Targeting Same
App 20190358205A1 - | 2019-11-28 |
Target Tissue-specific Antigen-binding Molecule
App 20190359704A1 - | 2019-11-28 |
Antigen-binding Domain, And Polypeptide Including Conveying Section
App 20190359721A1 - | 2019-11-28 |
Antibody Substituting For Function Of Blood Coagulation Factor Viii
App 20190359728A1 - | 2019-11-28 |
Anti-sclerostin Antibodies And Methods Of Use
App 20190352387A1 - | 2019-11-21 |
Aminopyrazole derivatives
Grant 10,479,780 - Ebiike , et al. Nov | 2019-11-19 |
Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
Grant 10,472,623 - Igawa , et al. Nov | 2019-11-12 |
Method for assaying soluble GPC3 protein
Grant 10,451,627 - Ohtomo , et al. Oc | 2019-10-22 |
Methods of treatment that include the administration of bispecific antibodies
Grant 10,450,381 - Igawa , et al. Oc | 2019-10-22 |
Antibody constant region variants with reduced Fcgammar binding
Grant 10,435,458 - Kuramochi , et al. O | 2019-10-08 |
Solid preparations containing tofogliflozin and process of producing the same
Grant 10,398,653 - Wada , et al. Sep | 2019-09-03 |
FGFR gatekeeper mutant gene and drug targeting same
Grant 10,391,081 - Nakanishi , et al. A | 2019-08-27 |
Nucleic acids encoding anti-C5 antibodies
Grant 10,385,122 - Ruike , et al. A | 2019-08-20 |
Preparation containing tetracyclic compound at high dose
Grant 10,350,214 - Tomimatsu , et al. July 16, 2 | 2019-07-16 |
Amorphous form of tetracyclic compound
Grant 10,344,014 - Shiraki , et al. July 9, 2 | 2019-07-09 |
Stabilized antibody-containing formulations
Grant 10,316,096 - Morichika , et al. | 2019-06-11 |
Method for evaluating coagulation ability of blood specimen, and reagent, reagent kit and device to be used therein
Grant 10,302,626 - Shima , et al. | 2019-05-28 |
Therapeutic antigen-binding molecule with a FcRn-binding domain that promotes antigen clearance
Grant 10,253,100 - Igawa , et al. | 2019-04-09 |
Antibody constant region variant
Grant 10,253,091 - Igawa , et al. | 2019-04-09 |
Solid preparations containing tofogliflozin and process of producing the same
Grant 10,231,930 - Wada , et al. | 2019-03-19 |
| 